Geneva, April 20 -- International Clinical Trials Registry received information related to the study (NCT07519135) titled 'A Study to Learn About the Medicine Called PF-08653944 in People With and Without Reduced Liver Function' on April 2.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Parallel Assignment. Primary purpose: Basic Science. Masking: None (Open Label).
Primary Sponsor: Pfizer
Condition:
Healthy
Intervention:
Drug: PF-08653944
Recruitment Status: Not recruiting
Phase: Phase 1
Date of First Enrollment: April 15, 2026
Target Sample Size: 26
To know more, visit https://clinicaltrials.gov/study/NCT07519135
Published by HT Digital Content Services with permission from Health Daily D...